Evidence map›Paper›PMID 39640072›Full record

ArticleAdvanced sensor research2024

Highly Reusable Electrochemical Immunosensor for Ultrasensitive Protein Detection.

Kavya L Singampalli, Camille Neal-Harris, Cassian Yee, Jamie S Lin, Peter B Lillehoj

Abstract read
In one paragraph

Article in Advanced sensor research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kavya L SingampalliDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Camille Neal-HarrisDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.
Cassian YeeDepartment of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, 77030, USA.
Jamie S LinSection of Nephrology, Division of Internal Medicine, UT MD Anderson Cancer Center, Houston, TX, 77030, USA.
Peter B LillehojDepartment of Bioengineering, Rice University, Houston, TX, 77030, USA.

Funding

The role of ARF6 in the progression of diabetic kidney diseaseK08DK119466 · NIDDK · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIN, JAMIE · 2019 to 2023
$826k
Serological test for detecting all geographical variances of Trypanosoma cruzi infectionR21AI171477 · NIAID · RICE UNIVERSITY · PI LILLEHOJ, PETER B · 2023 to 2024
$435k
NIAID NIH HHS R21 AI171477NIDDK NIH HHS K08 DK119466
6 · The paper itself

Abstract

The detection and quantification of protein biomarkers in bodily fluids is important for many clinical applications, including disease diagnosis and health monitoring. Current techniques for ultrasensitive protein detection, such as enzyme-linked immunosorbent assay (ELISA) and electrochemical sensing, involve long incubation times (1.5-3 hr) and rely on single-use sensing electrodes which can be costly and generate excessive waste. This work demonstrates a reusable electrochemical immunosensor employing magnetic nanoparticles (MNPs) and dually labeled gold nanoparticles (AuNPs) for ultrasensitive measurements of protein biomarkers. As proof of concept, this platform was used to detect C-X-C motif chemokine ligand 9 (CXCL9), a biomarker associated with kidney transplant rejection, immune nephritis from checkpoint inhibitor therapy, and drug-associated acute interstitial nephritis, in human urine. The sensor successfully detected CXCL9 at concentrations as low as 27 pg/mL within ~1 hr. This immunosensor was also adapted onto a handheld smartphone-based diagnostic device and used for measurements of CXCL9, which exhibited a lower limit of detection of 65 pg/mL. Lastly, we demonstrate that the sensing electrodes can be reused for at least 100 measurements with a negligible loss in analytical performance, reducing the costs and waste associated with electrochemical sensing.

Indexed as

CXCL9diagnosticelectrochemicalgold nanoparticlesimmunosensormagnetic nanoparticlesreusable

Identifiers

PMID39640072
PMCPMC11617009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.